DCGI Grants Permission to Bharat Biotech to Conduct Intranasal Booster Dose Trials
GG News Bureau
New Delhi, 28th Jan. The Drugs Controller General of India (DCGI) granted permission to Bharat Biotech to conduct clinical trials of intranasal vaccine BBV154 on Friday.
The Subject Expert Committee of the Central Drugs…